SUPERTEX, INC.
|
(Exact name of registrant as specified in its charter)
|
California
|
0-12718
|
94-2328535
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
1235 Bordeaux Drive, Sunnyvale, California
|
94089
|
(Address of principal executive offices)
|
(Zip Code)
|
(Former name or former address, if changed since last report.)
|
Supertex, Inc.
|
||
(Registrant)
|
||
Date: July 24, 2012
|
By
|
/s/ Phillip A. Kagel
|
Name
|
Phillip A. Kagel
|
|
Title
|
Vice President, Finance and Chief Financial Officer
|
|
99.1
|
Registrant's press release dated July 24, 2012, is furnished pursuant to Item 2.02 of Form 8-K.
|
Supertex, Inc.
|
News Release
|
FOR IMMEDIATE RELEASE
|
Corporate Headquarters:
|
Dr. Henry C. Pao
|
|
President & CEO
|
|
408/222-8888
|
SUPERTEX, INC.
|
||||||||
CONSOLIDATED BALANCE SHEET INFORMATION
|
||||||||
(unaudited)
|
||||||||
June 30, 2012
|
March 31, 2012
|
|||||||
(in thousands)
|
||||||||
ASSETS
|
||||||||
Cash and cash equivalents
|
$ | 13,415 | $ | 19,860 | ||||
Short term investments
|
134,258 | 111,137 | ||||||
Trade accounts receivable, net
|
7,754 | 8,021 | ||||||
Inventories
|
12,924 | 14,438 | ||||||
Deferred tax assets
|
7,545 | 7,529 | ||||||
Prepaid income taxes
|
3,017 | 3,032 | ||||||
Prepaid expenses and other current assets
|
6,914 | 6,786 | ||||||
Total current assets
|
185,827 | 170,803 | ||||||
Long term investments
|
13,600 | 25,900 | ||||||
Property, plant and equipment, net
|
4,674 | 4,941 | ||||||
Other assets
|
585 | 621 | ||||||
Deferred tax assets, noncurrent
|
5,344 | 5,375 | ||||||
TOTAL ASSETS
|
$ | 210,030 | $ | 207,640 | ||||
LIABILITIES
|
||||||||
Trade accounts payable
|
$ | 2,472 | $ | 1,994 | ||||
Accrued salaries and employee benefits
|
12,170 | 12,434 | ||||||
Other accrued liabilities
|
610 | 615 | ||||||
Deferred revenue
|
2,600 | 2,560 | ||||||
Income taxes payable
|
234 | 23 | ||||||
Total current liabilities
|
18,086 | 17,626 | ||||||
Income taxes payable, noncurrent
|
4,148 | 4,161 | ||||||
Deferred tax liabilities, noncurrent
|
127 | - | ||||||
Other accrued liabilities, noncurrent
|
564 | 561 | ||||||
Total liabilities
|
22,925 | 22,348 | ||||||
SHAREHOLDERS' EQUITY
|
||||||||
Common stock
|
69,060 | 68,031 | ||||||
Accumulated other comprehensive loss
|
(1,081 | ) | (1,345 | ) | ||||
Retained earnings
|
119,126 | 118,606 | ||||||
Total shareholders' equity
|
187,105 | 185,292 | ||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$ | 210,030 | $ | 207,640 |
SUPERTEX, INC.
|
||||||||||||
CONSOLIDATED INCOME STATEMENT INFORMATION
|
||||||||||||
(unaudited)
|
||||||||||||
Three Months Ended
|
||||||||||||
(in thousands, except per share amounts)
|
||||||||||||
June 30, 2012
|
March 31, 2012
|
July 2, 2011
|
||||||||||
Net sales
|
$ | 16,059 | $ | 16,451 | $ | 18,058 | ||||||
Cost of sales(1)
|
8,565 | 8,723 | 8,992 | |||||||||
Gross profit
|
7,494 | 7,728 | 9,066 | |||||||||
Research and development(1)
|
3,486 | 3,885 | 3,814 | |||||||||
Selling, general and administrative(1)
|
3,384 | 3,614 | 3,251 | |||||||||
Income from operations
|
624 | 229 | 2,001 | |||||||||
Interest and other income, net
|
202 | 837 | 368 | |||||||||
Income before income taxes
|
826 | 1,066 | 2,369 | |||||||||
Provision for (benefit from) income taxes
|
229 | (207 | ) | 700 | ||||||||
Net income
|
$ | 597 | $ | 1,273 | $ | 1,669 | ||||||
Net income per share:
|
||||||||||||
Basic
|
$ | 0.05 | $ | 0.11 | $ | 0.13 | ||||||
Diluted
|
$ | 0.05 | $ | 0.11 | $ | 0.13 | ||||||
Shares used in per share computation:
|
||||||||||||
Basic
|
11,999 | 12,044 | 12,755 | |||||||||
Diluted
|
12,001 | 12,048 | 12,777 | |||||||||
(1) Includes amortization of employee stock-based compensation as follows:
|
||||||||||||
Cost of sales
|
$ | 134 | $ | 156 | $ | 119 | ||||||
Research and development
|
$ | 349 | $ | 343 | $ | 246 | ||||||
Selling, general and administrative
|
$ | 262 | $ | 289 | $ | 228 |
SUPERTEX, INC.
|
||||||||||||
SUPPLEMENTAL RECONCILIATIONS OF GAAP TO NON-GAAP RESULTS
|
||||||||||||
(unaudited)
|
||||||||||||
Three Months Ended
|
||||||||||||
(in thousands, except per share amounts)
|
||||||||||||
June 30, 2012
|
March 31, 2012
|
July 2, 2011
|
||||||||||
GAAP net income
|
$ | 597 | $ | 1,273 | $ | 1,669 | ||||||
Adjustment for stock-based compensation included in:
|
||||||||||||
Cost of sales
|
134 | 156 | 119 | |||||||||
Research and development
|
349 | 343 | 246 | |||||||||
Selling, general and administrative
|
262 | 289 | 228 | |||||||||
Subtotal
|
745 | 788 | 593 | |||||||||
Tax effect of stock-based compensation
|
(18 | ) | (93 | ) | (19 | ) | ||||||
Non-GAAP net income excluding employee stock-based compensation
|
$ | 1,324 | $ | 1,968 | $ | 2,243 | ||||||
Non-GAAP net income per share:
|
||||||||||||
Basic
|
$ | 0.11 | $ | 0.16 | $ | 0.18 | ||||||
Diluted
|
$ | 0.11 | $ | 0.16 | $ | 0.18 | ||||||
Shares used in per share computation:
|
||||||||||||
Basic
|
11,999 | 12,044 | 12,755 | |||||||||
Diluted
|
12,001 | 12,048 | 12,777 |
SUPERTEX, INC.
|
||||||||||||
SUPPLEMENTAL RECONCILIATIONS OF GAAP TO NON-GAAP INCOME PER SHARE
|
||||||||||||
(unaudited)
|
||||||||||||
Three Months Ended
|
||||||||||||
(in thousands, except per share amounts)
|
||||||||||||
June 30, 2012
|
March 31, 2012
|
July 2, 2011
|
||||||||||
Shares used in per share computation: | ||||||||||||
Diluted
|
12,001 | 12,048 | 12,777 | |||||||||
DILUTED:
|
||||||||||||
GAAP net income per share
|
$ | 0.05 | $ | 0.11 | $ | 0.13 | ||||||
Adjustments to reconcile net income to non-GAAP net income per share:
|
||||||||||||
Employee stock-based compensation effects included in:
|
||||||||||||
Cost of sales
|
0.01 | 0.01 | 0.01 | |||||||||
Research and development
|
0.03 | 0.03 | 0.02 | |||||||||
Selling, general and administrative
|
0.02 | 0.02 | 0.02 | |||||||||
Provision for income taxes
|
(0.00 | ) | (0.01 | ) | (0.00 | ) | ||||||
Non-GAAP net income per share excluding employee stock-based compensation
|
$ | 0.11 | $ | 0.16 | $ | 0.18 |